1. When will we see a COVID-19 vaccine  Health-e News Service
  2. COVID-19: WHO reverses itself based on new discovery about the virus  Nairametrics
  3. The unknowns behind a Covid-19 vaccine: 'It's an unwritten book' - Dr Chris Smith  RNZ
  4. The unknowns behind a Covid-19 vaccine: 'It's an unwritten book'  New Zealand Herald
  5. View Full coverage on Google News
The results of Phase I trials have not been published by the Chongqing Zhifei Biological Products group.The results of Phase I trials have not been published by the Chongqing Zhifei Biological Products group.

China’s Zhifei starts Phase II trial of Covid-19 vaccine - world news - Hindustan Times

The biotech is strengthening its coronavirus vaccine production network.The biotech is strengthening its coronavirus vaccine production network.

Why Moderna Stock Jumped Today | The Motley Fool

The United States is the only developed nation unable to balance cost, efficacy and social good in setting prices.The United States is the only developed nation unable to balance cost, efficacy and social good in setting prices.

Analysis: How A COVID-19 Vaccine Could Cost Americans Dearly

Analysts have predicted that a battle for access to an effective vaccine could stretch into 2021 or 2022.

'Vaccine nationalism' could lead to the coronavirus devastating public health and the economy, experts warn

A week after the US Food and Drug Administration (FDA) issued guidance on vaccines to prevent coronavirus disease (COVID-19), Peter Marks, director of the Center for Biologics Evaluation and Research, shed light on the reasoning behind the agency’s 50% efficacy threshold and where the agency stands on challenge trials and emergency use authorizations (EUAs).

Marks on COVID-19 vaccine efficacy, EUAs and challenge trials | RAPS

MOSCOW (Sputnik) – Russia has started the final stage of testing the COVID-19 vaccine being developed by the Gamaleya Scientific Research Institute of Epidemiology and...MOSCOW (Sputnik) – Russia has started the final stage of testing the COVID-19 vaccine being developed by the Gamaleya Scientific Research Institute of Epidemiology and...

Russia Starts Final Stage of Testing COVID-19 Vaccine, Defence Ministry Says - Sputnik International

According to WHO, globally, there have been more than 12 million confirmed cases of COVID-19, including 549,247 deaths (as of 8:14 AM CEST, 10 July 2020). The r

Global Vaccine Developers Providing Excellent Returns: A lens on Novavax, INOVIO Pharmaceuticals, Moderna, BioNTech

Moderna is on a steady march to market with its mRNA-based COVID-19 vaccine, and it's snapping up manufacturing capacity along the way. After inking a fill-finish deal with major CDMO Catalent last month, Moderna has now put its name to a second pact, this time with Madrid-based Rovi. Moderna is on a steady march to market with its mRNA-based COVID-19 vaccine, and it's snapping up manufacturing capacity along the way. After inking a fill-finish deal with major CDMO Catalent last month, Moderna has now put its name to a second pact, this time with Madrid-based Rovi. 

Moderna inks fill-finish pact with Spain's Rovi for 'hundreds of millions' of COVID-19 shot doses | FiercePharma

403 Forbidden

Moderna (NASDAQ: MRNA) shares are trading higher on Thursday amid growing concerns of U.S. coronavirus cases. Dr. Anthony Fauci earlier said the company will likely be going into advanced Phase 3 trials by the end of July.Moderna is engaged in creating transformative medicines based on messenger RNA,Moderna (NASDAQ: MRNA) shares are trading higher on Thursday amid growing concerns of U.S. coronavirus cases. Dr. Anthony Fauci earlier said the company will likely be going into advanced Phase 3 trials by the end of July.Moderna is engaged in creating transformative medicines based on messenger RNA,

Why Moderna's Stock Is Trading Higher Today

MRNA stock does not fully reflect the benefits of a novel platform that is on the verge of commercializing vaccines.Moderna has novel platform that is on the verge of creating vaccines to protect us from some of the world’s dangerous viruses

MRNA Stock: Investors Should Look at Moderna’s Many Advantages | InvestorPlace

Moderna has novel platform that is on the verge of creating vaccines to protect us from some of the world’s dangerous viruses

MRNA Stock: Investors Should Look at Moderna’s Many Advantages | InvestorPlace

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for July 10, 2020.Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for July 10, 2020.

Biopharma Update on the Novel Coronavirus: July 10 | BioSpace

The sites for phase 1 and phase 2 clinical trials have been finalised and the trials are yet to begin, Union Health Ministry said during a press briefing.The sites for phase 1 and phase 2 clinical trials have been finalised and the trials are yet to begin, Union Health Ministry said during a press briefing.

ICMR's letter giving August 15 deadline for COVAXIN aimed at expediting trials: Government- The New Indian Express

Large coronavirus vaccine studies are going to take place throughout the summer and fall, and there is now a website where you can register for a chance to volunteer.Large coronavirus vaccine studies are going to take place throughout the summer and fall, and there is now a website where you can register for a chance to volunteer. More than one million American…

There’s a way you can get a coronavirus vaccine before everyone else – here’s what you need to know – BGR

A coronavirus vaccine will not be possible till at least next year, government officials told the parliamentary standing committee on science and technology on Friday, amid a global race by scientists and researchers to tackle the pandemic.A coronavirus vaccine will not be possible till at least next year, government officials told the parliamentary standing committee on science and technology on Friday, amid a global race by scientists and researchers to tackle the pandemic.

Coronavirus Vaccine - No COVID-19 Vaccine Possible Before 2021, Parliament Panel Told: Sources

Though the ICMR is aiming for an August 15 deadline, it is a moot question whether a timeline can be issued when different phases and trials have to be done to ensure safety.Though the ICMR is aiming for an August 15 deadline, it is a moot question whether a timeline can be issued when different phases and trials have to be done to ensure safety.

Race for the Vaccine

WHO Regional Office for Africa in Brazzaville, Congo, disclosed this on its official Twitter account @WHOAFRO, adding that there are nearly 150 COVID-19 vaccines received but the few were selected.WHO Regional Office for Africa in Brazzaville, Congo, disclosed this on its official Twitter account @WHOAFRO, adding that there are nearly 150 COVID-19 vaccines received but the few were selected.

COVID-19: 19 Vaccines In Clinical Trials —WHO | Sahara Reporters

A Seattle woman who was the first person in the U.S. to receive an experimental COVID-19 vaccine test shot says she feels “fantastic.”A Seattle woman who was the first person in the U.S. to receive an experimental COVID-19 vaccine test shot says she feels “fantastic.”

The African Union Commission just recently facilitated a program called the new Africa Centres for Disease Control and PreventionCONCVACT plans to capture more than ten late-stage vaccine trials at the earliest.

African Union begins COVID-19 vaccine trial group | Nairametrics

It would take at least a year to develop a vaccine to cure Covid-19 top government scientists and officials on Friday told a science, technology, environment and forests committee, according to multiple news reports. This time frame was an optimistic assessment regardless if it is developed in India or abroad, the scientists noted.It would take at least a year to develop a vaccine to cure Covid-19 top government scientists and officials on Friday told a science, technology, environment and forests committee, according to

Scientists say Covid-19 vaccine at least a year away: Report | Deccan Herald

The race to develop a COVID-19 vaccine is heating up globally and right here in our area. In Seattle, we’ve got a lot of companies and volunteers doing their part to try and help. “It’s been 16 weeks since I had the first dose," said Jennifer Haller of Ballard. "I feel fantastic. " On March 16, Haller, a 43-year-old a tech startup operations manager, became the first person in the country to get injected with the experimental COVID-19 vaccine.The race to develop a COVID-19 vaccine is heating up globally and right here in our area. In Seattle, we’ve got a lot of companies and volunteers doing their part to try and help. “It’s been 16 weeks since I had the first dose," said Jennifer Haller of Ballard. "I feel fantastic. " On March 16, Haller, a 43-year-old a tech startup operations manager, became the first person in the country to get injected with the experimental COVID-19 vaccine.

First Seattle volunteer in human COVID-19 vaccine trials says she feels 'fantastic' | KOMO

First Seattle volunteer in human COVID-19 vaccine trials says she feels 'fantastic'

Governments should always seek and respect the opinion of their scientific advisors – and responsible scientific advisors should stand up for what is right.

For a Better COVID-19 Vaccine, Scientists and Politicians Need to Work Together - The Wire Science

Moderna Inc (NASDAQ: MRNA) announced another manufacturing deal Thursday for mRNA-1273, its vaccine candidate for the novel coronavirus. Moderna Covering ...Moderna Inc (NASDAQ: MRNA) announced another manufacturing deal Thursday for mRNA-1273, its vaccine candidate for the novel coronavirus. Moderna Covering All Manufacturing Bases...

Moderna, Inc. (MRNA), Catalent (NYSE:CTLT) - Moderna Strikes Another Coronavirus Vaccine Manufacturing Deal To Ensure Overseas Supply | Benzinga

Biotech company Moderna has signed a deal with Spain's Laboratorios Farmacéuticos Rovi for fill-fini

Moderna inks potential Covid-19 vaccine manufacturing deal with with Spain’s Rovi – Public Radio of Armenia

Shares of Moderna Inc. undefined gained 0.5% in premarket trading on Thursday after the drugmaker announced another manufacturing deal for its still...Shares of Moderna Inc. undefined gained 0.5% in premarket trading on Thursday after the drugmaker announced another manufacturing deal for its still...

Moderna signs on for another COVID-19 vaccine manufacturing deal - MarketWatch

Volunteers who received a Russian-made Covid-19 vaccine have developed immunity to the virus, according to the country’s Ministry of Defense. Clinical trials for the drug are now in their final stage.Volunteers who received a Russian-made Covid-19 vaccine have developed immunity to the virus, according to the country’s Ministry of Defense. Clinical trials for the drug are now in their final stage.

As Russia begins final stage of coronavirus vaccine trial, volunteers are confirmed to have immunity – and no side effects — RT Russia News

The African Union Commission has launched a consortium for Covid-19 vaccine clinical trials aimed at securing more than 10 trials as early as possible.The African Union Commission has launched a consortium for Covid-19 vaccine clinical trials aimed at securing more than 10 trials as early as possible.

Africa begins collaboration for Covid-19 vaccine trial - MyJoyOnline.com

404 Not Found

There's a new website where people can volunteer to take a new COVID-19 vaccine before it's made available to the public.There's a new website where people can volunteer to take a new COVID-19 vaccine before it's made available to the public.

COVID NYC Update: Volunteer to take new COVID-19 vaccine via new website | abc7ny.com

A conversation with Dr. John Mascola, director of the vaccine research center at the National Institute of Allergy and Infectious Diseases.A conversation with Dr. John Mascola, director of the vaccine research center at the National Institute of Allergy and Infectious Diseases.

Meet the Researcher Leading NIH’s COVID-19 Vaccine Development Efforts - Government Executive

A viral meme claims schools will require students take a deadly COVID-19 vaccine before returning. That vaccine has not yet been approved.A viral meme claims schools will require students take a deadly COVID-19 vaccine before returning. That vaccine has not yet been approved.

Fact check: Schools do not require a COVID-19 vaccine for students

Global health agency says equity will be key in distribution of yet-to-be-developed Covid-19 cure.Global health agency says equity will be key in distribution of yet-to-be-developed Covid-19 cure.

Africa won’t miss out on vaccine, says WHO: The Standard

The meeting participants stressed the need for large phase 3 clinical trials that enroll many thousands of people, including those with underlying medical conditions, to generate relevant data for the key target populations

International regulators align positions on phase 3 COVID-19 vaccine trials - Express Pharma

The new federal website allows you to register for trials for the COVID-19 vaccineThe new federal website allows you to register for trials for the COVID-19 vaccine

Coronavirus: Vaccine trials for COVID-19 are coming. Here’s how to sign up - Deseret News

On Wednesday, a website launched by the National Institute of Allergy and Infectious Diseases may make it easier to find volunteers.On Wednesday, a website launched by the National Institute of Allergy and Infectious Diseases may make it easier to find volunteers.

Want to volunteer for a COVID-19 vaccine trial? Here’s how

Russian Defence Ministry, on Friday, stated that the country has begun the final clinical stage of testing a possible COVID-19 vaccine.Russian Defence Ministry, on Friday, stated that the country has begun the final clinical stage of testing a possible COVID-19 vaccine.

Russia begins last testing stage of COVID-19 vaccine - P.M. News

The Inter-Agency Task Force for the Management of Emerging Infectious Diseases has approved the collaboration with five coronavirus disease 2019 (Covid-19) vaccine manufacturers from China and Taiwan to be used in clinical trials in the country. The manufacturers are Chinese Academy of Science-Guangzhou Institute of Biomedicine and Health, Sinopharm-Wuhan Institute and Beijing Biologicals Institute and Sinovac Biotech […]

PH starts Covid-19 vaccine trials – The Manila Times

Indian Council of Medical Research scientist Nivedita Gupta said indigenous vaccine candidates have been developed for a new disease in record time.Indian Council of Medical Research scientist Nivedita Gupta said indigenous vaccine candidates have been developed for a new disease in record time.

India News: NEW DELHI: Almost a week after a controversy erupted over a letter from the director general of ICMR indicating August 15 as the deadline to launch a .India News: NEW DELHI: Almost a week after a controversy erupted over a letter from the director general of ICMR indicating August 15 as the deadline to launch a .

ICMR letter was intended to expedite jab trials: Govt | India News - Times of India

COVID news: Here's how to volunteer for a coronavirus vaccine trial | 6abc.com